Exosomes in cancer drug resistance: dual roles in therapy failure and emerging precision therapeutics
Open Access
- 20 July 2026
- journal article
- review article
- Published by Springer Nature in Cancer Cell International
- Vol. 26 (1)
Abstract
Exosomes play a key role in cancer, functioning both as drivers of drug resistance and as tools for therapy. Tumor-derived exosomes facilitate intercellulaKeywords
This publication has 193 references indexed in Scilit:
- The Exosome‐Lactate‐Lactylation Axis: A Metabolic‐Epigenetic Circuit Driving Tumor Immune EvasionComprehensive Physiology, 2026
- Exploring Regulatory Frameworks for Exosome Therapy: Insights and PerspectivesHealth Care Science, 2025
- Recent Advances in Plasmonic Sensing Techniques for Exosome Detection and Composition AnalysisLaser & Photonics Reviews, 2024
- Challenges of MS‐based small extracellular vesicles proteomicsJournal of Extracellular Vesicles, 2024
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- Chronic nSMase2 Inhibition Suppresses Neuronal Exosome Spreading In Vivo & Induces Sex‐Specific Attenuation of AD Pathology in APPNL‐F/NL‐F Knock‐In MiceAlzheimer's & Dementia, 2023
- Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and ImplicationsAdvanced Science, 2022
- Exosomes and their roles in the chemoresistance of pancreatic cancerCancer Medicine, 2022
- The roles of exosomes in cancer drug resistance and its therapeutic applicationClinical and Translational Medicine, 2020
- Tunable Resistive Pulse Sensing for the Characterization of Extracellular Vesicles2016